Mar 26, 2024 | Featured, Maryland, News, Science
Bookmark (0) Please login to bookmarkClose Username or Email Address Password Remember Me Opus Genetics has announced vision improvements for the first three adult patients in its Phase ½ gene therapy clinical trial for Leber congenital amaurosis 5 (LCA5), a rare,...
